Inside Innovation is a new lecture series developed by the UC San Diego Research Affairs, Office of Innovation and Commercialization (OIC), to showcase the latest innovative technologies developed across UC San Diego. The series is held monthly at the Roth auditorium of the Sanford Consortium for Regenerative Medicine. This forum provides a robust venue bringing together the general public, entrepreneurs, investors and all academic members to engage and interact with UC San Diego researchers and the staff of the OIC. The series has been highly successful with many attendees expressing their interest in continuing to have this engagement opportunity with UC San Diego researchers.
Past and Upcoming Presentations
|Mutagenic Chain Reaction/ Gene Drive/ Editing|
Ethan Bier and Valentino Gantz
-Professor Ethan Bier and Research Scientist Valentino Gantz, collaborators on the new DARPA project, recently developed a breakthrough gene-drive technology called Active Genetics, which controls the transmission of genetic traits.
-The technology is a driving force behind the new Tata Institute for Genetics and Society (TIGS),established last year to focus on immunizing mosquitoes in the Anopheline genus against malaria disease transmission in India.
Presentation on Oct. 17, 2017. Register
|Neurodegenerative Disease/ ALS/ Alzheimer's|
-Research Scientist/ Assistant Professor in the Department of Anesthesia at UCSD and at the VA San Diego Healthcare System.
-One major research goal is to enhance pro-survival signaling that promotes dendritic growth, axonal sprouting, and re-organization of neuronal circuitry in the traumatically injured, ischemic, and aging brain.
Presentation on Nov. 7, 2017. Register
|Brain Imaging/ New Tools to Enhance MRI Scans for Research and Clinical Applications|
-Prof. Larry Frank's primary area of expertise is in diffusion imaging, including pulse sequence development, image reconstruction, and data analysis.
-He is Director of the Center for Scientific Computation in Imaging, UCSD.
-The goal of the Center is to bridge the gap between image acquisition and the quantitative understanding of physical systems by facilitating the development of computational and visualization tools.
Presentation on Jan. 16, 2018 Register
|DNA Editing to Treat MD, ALS, and Huntington's|
-Professor Gene Yeo is a leader in the development of computational and experimental approaches to understand mechanistic details of how RBPs control post-transcriptional regulatory networks in development and disease (neurodegeneration).
-His lab is committed to developing RNA-sensitive nanotechnologies that utilize differences in RNA content in cells to alter cellular behavior, linking our efforts to deeply understand RNA biology with engineering applications derived from that knowledge.
Presentation on Feb. 13, 2018 Register
|Drug Delivery Systems|
"On the Brink of an RNAi Therapeutics Revolution: Overcoming a Billion Years of Evolutionary Defenses"
RNAi therapeutics have great potential to treat human disease; however, due to a billion years of evolutionary defenses, delivery into the cytoplasm remains the rate limiting step. I will discuss the barriers and potential solutions making their way from basic discovery to clinical trials for RNAi therapeutics.
Presentation on Mar. 13, 2018 Register
- Dr. Chen’s research focuses on developing advanced nano/micro-manufacturing processes and nano/micro-mechanical systems for biomedical and life sciences applications.
- The goal of his research is to overcome the technical limitations of large scale conventional manufacturing processes, develop new processes and nano/micro-devices with good understanding of fundamental physics and chemistry, and to use these nano/micro-systems to advance health care.
Presentation on Apr. 17 2018. Register
|"Disease in a Dish" Brain Models|
-Professor University of California San Diego UCSD Stem Cell Program School of Medicine Dept.
-The Muotri lab explores mobile elements as generators of diversity during neuronal differentiation. These mobile elements may be part of a conserved genetic core process responsible for evoking facilitated complex non-random phenotypical variation upon which selection may act.
Presentation on May. 17 2018. Register